Targeting of Head and Neck Cancer by Radioiodinated CLR1404 in Murine Xenograft Tumor Models with Partial Volume Corrected Theranostic Dosimetry
Cancer Biotherapy and Radiopharmaceuticals · 2023
DOI: 10.1089/cbr.2022.0084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, 2023. Verfasst von Ian R Marsh und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology and Molecular Radiation Sciences, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Iodine Radioisotopes, Head and Neck Neoplasms. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology and Molecular Radiation Sciences, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
- Department of Medical Physics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
- Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
- Department of Biostatistics and Medical Informatics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
- Department of Radiology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
ORCID-Profile: Ian R Marsh, David P Adam
Zitieren
APA
Marsh, I. R., Li, C., Grudzinski, J., Jeffery, J., Longhurst, C., Adam, D. P., Hernandez, R., Weichert, J. P., Harari, P. M., & Bednarz, B. P. (2023). Targeting of Head and Neck Cancer by Radioiodinated CLR1404 in Murine Xenograft Tumor Models with Partial Volume Corrected Theranostic Dosimetry. Cancer Biotherapy and Radiopharmaceuticals. https://doi.org/10.1089/cbr.2022.0084
Vancouver
Marsh IR, Li C, Grudzinski J, Jeffery J, Longhurst C, Adam DP, et al. Targeting of Head and Neck Cancer by Radioiodinated CLR1404 in Murine Xenograft Tumor Models with Partial Volume Corrected Theranostic Dosimetry. Cancer Biotherapy and Radiopharmaceuticals. 2023. doi:10.1089/cbr.2022.0084
BibTeX
@article{Marsh2023,
author = {Marsh, Ian R and Li, Chunrong and Grudzinski, Joseph and Jeffery, Justin and Longhurst, Colin and Adam, David P and Hernandez, Reinier and Weichert, Jamey P and Harari, Paul M and Bednarz, Bryan P},
title = {Targeting of Head and Neck Cancer by Radioiodinated CLR1404 in Murine Xenograft Tumor Models with Partial Volume Corrected Theranostic Dosimetry},
journal = {Cancer Biotherapy and Radiopharmaceuticals},
year = {2023},
doi = {10.1089/cbr.2022.0084}
}
EUVIMED